Sort
23,748 grants matching “melanoma”
UNIV OF IOWA CALGB INSTITUTIONAL GRANT
$139,373University Of Iowa · U10 · FY2001 · CA
IMMUNE RESPONSE TO THE MUTATED GP?00 PEPTIDE (209O-2M)
$139,348Providence Portland Medical Center · R21 · FY2000 · CA
Community Outreach and Engagement
$139,334Chau Trinh-Shevrin · New York University School Of Medicine · P30 · FY2019 · CA
Discovery of Chromosome Arm 11q Tumor Suppressor Genes in Neuroblastoma
$139,320Edward F Attiyeh · Children'S Hosp Of Philadelphia · K08 · FY2010 · CA
Discovery of Chromosome Arm 11q Tumor Suppressor Genes in Neuroblastoma
$139,320Edward F Attiyeh · Children'S Hosp Of Philadelphia · K08 · FY2007 · CA
Discovery of Chromosome Arm 11q Tumor Suppressor Genes in Neuroblastoma
$139,320Edward F Attiyeh · Children'S Hosp Of Philadelphia · K08 · FY2008 · CA
Discovery of Chromosome Arm 11q Tumor Suppressor Genes in Neuroblastoma
$139,320Edward F Attiyeh · Children'S Hosp Of Philadelphia · K08 · FY2009 · CA
Inhibition of MYC interactions with chromatin-remodeling factors as a novel anti-melanoma strategy
$139,280Mikhail Nikiforov · Roswell Park Cancer Institute Corp · R21 · FY2017 · CA
CYSTATIN C EFFECT ON B16 MELANOMA METASTASIS
$139,277A.T. Still University Of Health Sciences · R01 · FY2001 · CA
Community Outreach and Engagement
$139,228Tracy Onega · University Of Utah · P30 · FY2024 · CA
Role of GPR56 in glomerular endothelial cell injury in early diabetic kidney disease
$138,974Jia Fu · Icahn School Of Medicine At Mount Sinai · K01 · FY2023 · DK
Role of GPR56 in glomerular endothelial cell injury in early diabetic kidney disease
$138,974Jia Fu · Icahn School Of Medicine At Mount Sinai · K01 · FY2024 · DK
Role of GPR56 in glomerular endothelial cell injury in early diabetic kidney disease
$138,974Jia Fu · Icahn School Of Medicine At Mount Sinai · K01 · FY2022 · DK
Role of GPR56 in glomerular endothelial cell injury in early diabetic kidney disease
$138,974Jia Fu · Icahn School Of Medicine At Mount Sinai · K01 · FY2025 · DK
Development of Novel Markers for Melanoma Progression
$138,908Byungwoo Ryu · Nevada Cancer Institute · K01 · FY2008 · CA
CANCER AND LEUKEMIA GROUP B
$138,894Upstate Medical University · U10 · FY2000 · CA
Replacement of essential core instrument that can no longer be supported for service contract
$138,886Robert M Stroud · University Of California, San Francisco · R01 · FY2022 · GM
Administrative Core
$138,874Jane Amanda Skok · New York University School Of Medicine · P01 · FY2023 · CA
Identification of Molecular Factors Associated with Response to Interleukin-2
$138,829James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Population-Based Approach to Skin Cancer Epidemiology
$138,820Abrar A Qureshi · Brigham And Women'S Hospital · K07 · FY2008 · CA
Population-Based Approach to Skin Cancer Epidemiology
$138,820Abrar A Qureshi · Brigham And Women'S Hospital · K07 · FY2006 · CA
Population-Based Approach to Skin Cancer Epidemiology
$138,820Abrar A Qureshi · Brigham And Women'S Hospital · K07 · FY2007 · CA
IFI16 is a Periodontitis Modulating Protein
$138,811Julie Teresa Marchesan · Univ Of North Carolina Chapel Hill · K01 · FY2022 · DE
Consolidated Basic Cancer Research Program
$138,748Dario C. Altieri · Wistar Institute · P30 · FY2015 · CA
Cancer Epigenetics Training Program
$138,682Feng-Chun Yang · University Of Miami School Of Medicine · T32 · FY2018 · CA